Fentanyl Patch, Extended Release
Product Images NDC 50742-554

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Fentanyl (NDC 50742-554). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton 100 Mcg (Carton 100 Mcg)

Carton 100 Mcg (Carton 100 Mcg)
This text appears to be information about a Fentanyl Transdermal System. It includes details such as the strength (100 meg/h), NDC code (50742-556-05), instructions not to use if the seal on the blister is broken, a warning to keep out of reach of children, and the manufacturing date (08/16/2008). Additionally, the text emphasizes not using the system for more than 72 hours.*
FDA Label Image

Carton 12 Mcg (Carton 12 Mcg)

Carton 12 Mcg (Carton 12 Mcg)
Description not available.*
FDA Label Image

Carton 25 Mcg (Carton 25 Mcg)

Carton 25 Mcg (Carton 25 Mcg)
FDA Label Image

Carton 37.5 Mcg (Carton 37 5 Mcg)

Carton 37.5 Mcg (Carton 37 5 Mcg)
This is a description in regards to a Fentanyl Transdermal System that delivers medication at a rate of 37.5 meg/h. It should not be used if the seal on the blister is broken and should be kept out of reach of children. The text also seems to include cautionary instructions and dosage information.*
FDA Label Image

Carton 50 Mcg (Carton 50 Mcg)

Carton 50 Mcg (Carton 50 Mcg)
FDA Label Image

Carton 62.5 Mcg (Carton 62 5 Mcg)

Carton 62.5 Mcg (Carton 62 5 Mcg)
FDA Label Image

Carton 75 Mcg (Carton 75 Mcg)

Carton 75 Mcg (Carton 75 Mcg)
FDA Label Image

Carton 87.5 Mcg (Carton 87 5 Mcg)

Carton 87.5 Mcg (Carton 87 5 Mcg)
FDA Label Image

Figure A To D (Figure A D)

Figure A To D (Figure A D)
FDA Label Image

Figure E (Figure E)

Figure E (Figure E)
FDA Label Image

Figure F (Figure F)

Figure F (Figure F)
FDA Label Image

Figure G (Figure G)

Figure G (Figure G)
FDA Label Image

Figure H (Figure H)

Figure H (Figure H)
FDA Label Image

Figure I To J (Figure I J)

Figure I To J (Figure I J)
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
FDA Label Image
Logo (Logo)
FDA Label Image

Logo (Logo1)

Logo (Logo1)
FDA Label Image

Logo (Logo2)

Logo (Logo2)
FDA Label Image

Patch (Patch)

Patch (Patch)
This text mentions three different layers related to a drug product: "Release Liner", "Drug Containing Layer", and "Backing Layer". The release liner is used to protect the drug product during storage and handling. The drug-containing layer refers to the part of the product that contains the active ingredients or drugs. The backing layer acts as a support for the drug-containing layer. Each of these layers plays a critical role in the functionality and effectiveness of the drug product.*
FDA Label Image

Patch (Patch2)

Patch (Patch2)
This text mentions the components of a drug delivery system, including a release liner, a drug-containing layer, and a backing layer. These elements are typically part of patch-style medication systems where the release liner is removed before application, revealing the drug-containing layer that is directly applied to the skin, with the backing layer providing support.*
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.